Arthritic Microenvironment Actuated Nanomotors for Active Rheumatoid Arthritis Therapy

Increasing O(2) demand and excessive ROS production are the main features of arthritic microenvironment in rheumatoid arthritis (RA) joints and further play pivotal roles in inflammation exacerbation. In this work, a system of in situ regulation of arthritic microenvironment based on nanomotor strategy is proposed for active RA therapy. The synthesized MnO(2)‐motors enable catalytic regulation of RA microenvironment by consuming the overproduced H(2)O(2) and generating O(2) synergistically. The generated O(2) under H(2)O(2)‐rich conditions functions as inflammation detector, propellant for enhanced diffusion, as well as ameliorator for the hypoxic synovial microenvironment. Owing to O(2) generation and inflammation scavenging, the MnO(2)‐motors block the re‐polarization of pro‐inflammatory macrophages, which results in significantly decreased secretion of multiple pro‐inflammatory cytokines both in vitro and in vivo. In addition, intra‐articular administration of MnO(2)‐motors to collagen‐induced arthritis rats (CIA rats) effectively alleviates hypoxia, synovial inflammation, bone erosion, and cartilage degradation in joints. Therefore, the proposed arthritic regulation strategy shows great potential to seamlessly integrate basic research of RA with clinical translation.